参考文献/References:
[1] 孙莉萍,孟军,张毅,等.2型糖尿病合并桥本甲状腺炎患者血清微小RNA-22-5p和25羟维生素D水平变化及其预测价值研究[J].陕西医学杂志,2023,52(9):1177-1180,1185.
[2] 李志坤,魏丹蕾,杨树月,等.柴胡桂枝干姜汤对2型糖尿病大鼠肠道菌群及短链脂肪酸的影响研究[J].陕西中医,2024,45(6):757-762.
[3] 刘林峰,王红艳,曹俊,等.社区老年2型糖尿病患者自我隐瞒、益处发现和社会衰弱的相关性研究[J].保健医学研究与实践,2024,21(7):27-32.
[4] DURMAZ E,IKITIMUR B,KARADAG B,et al.The impact of atherosclerotic risk factors on disease progression in patients with previously diagnosed no obstructive coronary artery disease:Factors affecting coronary artery disease progression[J].Croon Artery Dis,2020,31(4):365-371.
[5] JOH J H,CHO S.Cardiovascular risk of carotid atherosclerosis:Global consensus beyond societal guidelines[J].The Lancet Global Health,2020,8(5):e625-e626.
[6] NONTERAH E A,BOATENG D,CROWTHER N J,et al.Carotid atherosclerosis,microalbuminuria,and estimated 10-year atherosclerotic cardiovascular disease risk in sub-saharan africa[J].JAMA Network Open,2022,5(4):e227559.
[7] GOVINDAN R B,MASSARO A N,KOTA S,et al.Effect of EKG sampling rate on heart rate variability analysis[J].Annu Int Conf IEEE Eng Med Biol Soc,2019,2019:6780-6783.
[8] SAHU I,UKIL A,KHANDELWAL S,et al.AFSense-ECG:Atrial fibrillation condition sensing from single lead Electrocardiogram(ECG)signals[J].IEEE Sensors Journal,2022,22(12):12269-12277.
[9] 中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组.中国头颈部动脉粥样硬化诊治共识[J].中华神经科杂志,2017,50(8):572-578.
[10] 石艳红,邵英.生物钟相关基因CLOCK及褪黑素受体MT1和MT2基因与2型糖尿病患者肠道菌群及炎症因子相关性分析[J].陕西医学杂志,2023,52(3):335-339.
[11] 李捷,郑雅峰,沈瑛锴,等.基于“一气周流”理论思想探析2型糖尿病的辨治思路[J].陕西中医,2023,44(12):1762-1766.
[12] BUDOFF M J,YOUNG R,BURKE G,et al.Ten-year association of coronary artery calcium with atherosclerotic cardiovascular disease(ASCVD)events:The multi-ethnic study of atherosclerosis(MESA)[J].Eur Heart J,2018,39(25):2401-2408.
[13] AZEMI A K,MOKHTAR S S,SHARIF S E T,et al.Clinacanthus nutans attenuates atherosclerosis progression in rats with type 2 diabetes by reducing vascular oxidative stress and inflammation[J].Pharm Biol,2021,59(1):1432-1440.
[14] 张艺.心电图PR、QT、QTc间期延长与糖尿病视网膜病变和颈动脉粥样硬化的相关性分析[D].西安:中国人民解放军空军军医大学,2017.
[15] PHAM H N,HOLMSTROM L,CHUGH H,et al.Dynamic electrocardiogram changes are a novel risk marker for sudden cardiac death[J].Eur Heart J,2024,45(10):809-819.
[16] RAUTAHARJU P M,ZHANG Z M,HAISTY W K,et al.Electrocardiographic repolarization-related predictors of coronary heart disease and sudden cardiac deaths in men and women with cardiovascular disease in the Atherosclerosis Risk in Communities(ARIC)study[J].J Electrocardiol,2015,48(1):101-110.
[17] AL-MOSAWI A A,NAFAKHI H,HASSAN M B,et al.ECG markers of arrythmogenic risk relationships with pericardial fat volume and BMI in patients with coronary atherosclerosis[J].J Electrocardiol,2018,51(4):569-572.
[18] 李莉.超重或肥胖患者QT、QTc、PR间期与动脉粥样硬化相关性分析[J].浙江临床医学,2023,25(7):1043-1045.
[19] ZHANG S,ZHUANG X,LV Q,et al.Six-year change in qt interval duration and risk of incident heart failure:A secondary analysis of the atherosclerosis risk in communities study[J].Circ J,2021,85(5):640-646.
[20] EDGAR L,AKBAR N,BRAITHWAITE A T,et al.Hyperglycemia induces trained immunity in macrophages and their precursors and promotes atherosclerosis[J].Circulation,2021,144(12):961-982.
[21] STONE P H,LIBBY P,BODEN W E.Fundamental pathobiology of coronary atherosclerosis and clinical implications for chronic ischemic heart disease management-the plaque hypothesis:A narrative review[J].JAMA Cardiol,2023,8(2):192-201.
[22] 范鸿儒,王栋,张帆,等.葱白提取物通过PPARγ/HO-1途径对动脉粥样硬化大鼠血脂异常和炎症反应的调节作用[J].检验医学与临床,2024,21(9):1208-1213.
[23] ZHANG W,SPEISER J L,YE F,et al.High-sensitivity c-reactive protein modifies the cardiovascular risk of lipoprotein(a):Multi-ethnic study of atherosclerosis[J].J Am Coll Cardiol,2021,78(11):1083-1094.
[24] 邓欣,孟达,吴静宜,等.余甘子总酚对动脉粥样硬化ApoE-/-小鼠肝脏保护作用机制的研究[J].中国病理生理杂志,2022,38(9):1608-1617.